Common Equity: The sum of all common equity items.
Johnson & Johnson (JNJ) had Common Equity of $81.54B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$24.56B |
|
$5.12B |
|
$7.97B |
|
$16.60B |
|
$19.60B |
|
$4.97B |
|
-- |
|
$4.97B |
|
$4.97B |
|
$5.12B |
|
$5.12B |
|
$5.12B |
|
$5.12B |
|
$5.42B |
|
$7.43B |
|
2.41B |
|
2.43B |
|
$2.12 |
|
$2.08 |
|
| Balance Sheet Financials | |
$55.62B |
|
$23.17B |
|
$143.59B |
|
$199.21B |
|
$54.13B |
|
$39.44B |
|
$63.54B |
|
$117.67B |
|
|
Common Equity |
$81.54B |
$-17.63B |
|
$81.54B |
|
2.41B |
|
| Cash Flow Statement Financials | |
$24.53B |
|
$-23.59B |
|
$-5.54B |
|
$24.11B |
|
$19.71B |
|
$-4.40B |
|
$1.35B |
|
$-12.38B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
0.33 |
|
0.59 |
|
67.56% |
|
20.22% |
|
22.05% |
|
-- |
|
20.22% |
|
20.83% |
|
$20.42B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.56 |
|
1.43 |
|
62.94 |
|
6.27% |
|
-29.02% |
|
2.57% |
|
4.23% |
|
$33.86 |
|
$8.40 |
|
$10.10 |
|